Astellas Pharma Inc. (4503.T)
JPY 1337.0
(1.83%)
JPY 1337.0
(1.83%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3569.6 Billion JPY | 45.31% |
| 2022 | 2456.51 Billion JPY | 5.32% |
| 2021 | 2332.39 Billion JPY | 2.58% |
| 2020 | 2273.62 Billion JPY | -1.92% |
| 2019 | 2318.16 Billion JPY | 22.16% |
| 2018 | 1897.64 Billion JPY | 2.12% |
| 2017 | 1858.2 Billion JPY | 2.05% |
| 2016 | 1820.9 Billion JPY | 1.2% |
| 2015 | 1799.33 Billion JPY | 0.32% |
| 2014 | 1793.57 Billion JPY | 8.5% |
| 2013 | 1653.1 Billion JPY | 14.36% |
| 2012 | 1445.56 Billion JPY | 3.21% |
| 2011 | 1400.62 Billion JPY | 4.91% |
| 2010 | 1335.09 Billion JPY | -2.13% |
| 2009 | 1364.17 Billion JPY | 1.17% |
| 2008 | 1348.44 Billion JPY | -6.3% |
| 2007 | 1439.15 Billion JPY | -2.15% |
| 2006 | 1470.7 Billion JPY | -7.18% |
| 2005 | 1584.52 Billion JPY | 73.44% |
| 2004 | 913.56 Billion JPY | 1.2% |
| 2003 | 902.69 Billion JPY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 3735.51 Billion JPY | 4.65% |
| 2024 Q2 | 3462.23 Billion JPY | -7.32% |
| 2023 Q4 | 3569.6 Billion JPY | 5.96% |
| 2023 FY | 3569.6 Billion JPY | 45.31% |
| 2023 Q3 | 3368.68 Billion JPY | -4.92% |
| 2023 Q2 | 3543.02 Billion JPY | 26.63% |
| 2023 Q1 | 2797.95 Billion JPY | 13.9% |
| 2022 FY | 2456.51 Billion JPY | 5.32% |
| 2022 Q2 | 2583.66 Billion JPY | 4.1% |
| 2022 Q3 | 2513.94 Billion JPY | -2.7% |
| 2022 Q4 | 2456.51 Billion JPY | -2.28% |
| 2022 Q1 | 2481.84 Billion JPY | 6.41% |
| 2021 FY | 2332.39 Billion JPY | 2.58% |
| 2021 Q1 | 2249.45 Billion JPY | -1.06% |
| 2021 Q2 | 2261.5 Billion JPY | 0.54% |
| 2021 Q3 | 2356.24 Billion JPY | 4.19% |
| 2021 Q4 | 2332.39 Billion JPY | -1.01% |
| 2020 FY | 2273.62 Billion JPY | -1.92% |
| 2020 Q1 | 2256.03 Billion JPY | -2.68% |
| 2020 Q4 | 2273.62 Billion JPY | -1.01% |
| 2020 Q2 | 2237.01 Billion JPY | -0.84% |
| 2020 Q3 | 2296.84 Billion JPY | 2.67% |
| 2019 Q3 | 1989.77 Billion JPY | 0.5% |
| 2019 FY | 2318.16 Billion JPY | 22.16% |
| 2019 Q2 | 1979.81 Billion JPY | 2.74% |
| 2019 Q1 | 1927.03 Billion JPY | 1.55% |
| 2019 Q4 | 2318.16 Billion JPY | 16.5% |
| 2018 Q1 | 1866.55 Billion JPY | 0.45% |
| 2018 Q4 | 1897.64 Billion JPY | -1.59% |
| 2018 Q3 | 1928.32 Billion JPY | 2.19% |
| 2018 FY | 1897.64 Billion JPY | 2.12% |
| 2018 Q2 | 1886.92 Billion JPY | 1.09% |
| 2017 FY | 1858.2 Billion JPY | 2.05% |
| 2017 Q1 | 1901.23 Billion JPY | 4.41% |
| 2017 Q4 | 1858.2 Billion JPY | -3.91% |
| 2017 Q3 | 1933.83 Billion JPY | 2.01% |
| 2017 Q2 | 1895.71 Billion JPY | -0.29% |
| 2016 Q2 | 1713.18 Billion JPY | 1.15% |
| 2016 FY | 1820.9 Billion JPY | 1.2% |
| 2016 Q4 | 1820.9 Billion JPY | -1.78% |
| 2016 Q3 | 1853.93 Billion JPY | 8.22% |
| 2016 Q1 | 1693.62 Billion JPY | -5.88% |
| 2015 FY | 1799.33 Billion JPY | 0.32% |
| 2015 Q2 | 1770.67 Billion JPY | -0.52% |
| 2015 Q1 | 1780 Billion JPY | -0.76% |
| 2015 Q3 | 1787.8 Billion JPY | 0.97% |
| 2015 Q4 | 1799.33 Billion JPY | 0.65% |
| 2014 Q2 | 1715.34 Billion JPY | 6.13% |
| 2014 Q4 | 1793.57 Billion JPY | -3.15% |
| 2014 Q3 | 1851.85 Billion JPY | 7.96% |
| 2014 FY | 1793.57 Billion JPY | 8.5% |
| 2014 Q1 | 1616.27 Billion JPY | -2.23% |
| 2013 Q2 | 1497.12 Billion JPY | 1.77% |
| 2013 Q3 | 1565.17 Billion JPY | 4.55% |
| 2013 Q4 | 1653.1 Billion JPY | 5.62% |
| 2013 FY | 1653.1 Billion JPY | 14.36% |
| 2013 Q1 | 1471.06 Billion JPY | 1.76% |
| 2012 Q4 | 1445.56 Billion JPY | 1.94% |
| 2012 Q3 | 1418.07 Billion JPY | 7.47% |
| 2012 Q2 | 1319.49 Billion JPY | -1.25% |
| 2012 Q1 | 1336.12 Billion JPY | -4.61% |
| 2012 FY | 1445.56 Billion JPY | 3.21% |
| 2011 FY | 1400.62 Billion JPY | 4.91% |
| 2011 Q2 | 1326.94 Billion JPY | -1.83% |
| 2011 Q1 | 1351.73 Billion JPY | 1.25% |
| 2011 Q4 | 1400.62 Billion JPY | 3.08% |
| 2011 Q3 | 1358.84 Billion JPY | 2.4% |
| 2010 Q4 | 1335.09 Billion JPY | 2.52% |
| 2010 FY | 1335.09 Billion JPY | -2.13% |
| 2010 Q3 | 1302.31 Billion JPY | -3.91% |
| 2010 Q1 | 1341.3 Billion JPY | -1.68% |
| 2010 Q2 | 1355.24 Billion JPY | 1.04% |
| 2009 FY | 1364.17 Billion JPY | 1.17% |
| 2009 Q2 | 1386.96 Billion JPY | 0.0% |
| 2009 Q4 | 1364.17 Billion JPY | 0.09% |
| 2009 Q3 | 1362.91 Billion JPY | -1.73% |
| 2008 Q4 | 1348.44 Billion JPY | 0.0% |
| 2008 FY | 1348.44 Billion JPY | -6.3% |
| 2007 FY | 1439.15 Billion JPY | -2.15% |
| 2006 FY | 1470.7 Billion JPY | -7.18% |
| 2005 FY | 1584.52 Billion JPY | 73.44% |
| 2004 FY | 913.56 Billion JPY | 1.2% |
| 2003 FY | 902.69 Billion JPY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Kyowa Kirin Co., Ltd. | 1025.94 Billion JPY | -247.934% |
| Chugai Pharmaceutical Co., Ltd. | 1932.54 Billion JPY | -84.71% |
| Ono Pharmaceutical Co., Ltd. | 913.66 Billion JPY | -290.689% |
| Santen Pharmaceutical Co., Ltd. | 435.69 Billion JPY | -719.282% |
| JCR Pharmaceuticals Co., Ltd. | 102.22 Billion JPY | -3391.874% |
| Daiichi Sankyo Company, Limited | 3461.13 Billion JPY | -3.134% |
| Otsuka Holdings Co., Ltd. | 3361.24 Billion JPY | -6.199% |
| Perseus Proteomics Inc. | 1.69 Billion JPY | -210644.003% |